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Summary
We present a Bayesian hierarchical model for detecting differentially expressing genes
that includes simultaneous estimation of array effects, and show how to use the output
for choosing lists of genes for further investigation. We give empirical evidence that
expression-level dependent array effects are needed, and explore different non-linear
functions as part of our model-based approach to normalization. The model includes
gene-specific variances but imposes some necessary shrinkage through a hierarchical
structure. Model criticism via posterior predictive checks is discussed. Modelling the
array effects (normalization) simultaneously with differential expression gives fewer false
positive results. To choose a list of genes, we propose to combine various criteria (for
instance, fold change and overall expression) into a single indicator variable for each
gene. The posterior distribution of these variables is used to pick the list of genes,
thereby taking into account uncertainty in parameter estimates. In an application to
∗email: a.m.lewin@imperial.ac.uk
mouse knockout data, Gene Ontology annotations over and under-represented amongst
the genes on the chosen list are consistent with biological expectations.
Key words: Microarray; Differential Expression; Normalization; Bayesian analysis;
Hierarchical model; Model checks; MCMC; WinBUGS
1. Introduction
Analysing gene expression data is a complex process due to the many sources of vari-
ability, both obscuring and interesting, that combine to produce the recorded level of
transcription. Reviews of the underlying biological process have been written by many
authors (e.g. Nguyen et al., 2002, and references therein). In this paper we are concerned
with modelling differential gene expression between two experimental conditions.
In early studies, differential gene expression was assessed using the fold change of
genes under different conditions (Chen, Dougherty, & Bittner, 1997). This is straight-
forward, but as genes are known to vary widely under different conditions, raw fold
change measures are not directly comparable between genes. Recently, differential ex-
pression has been assessed using standardised fold change, which is the fold change
divided by an estimate of its variability (e.g. Tusher, Tibshirani, & Gilbert, 2001).
One recognised difficulty is that most microarray experiments have very small num-
bers of replicate arrays. In order to obtain stable results, further assumptions are
needed on the variability of gene expression between replicates under the same con-
dition. The SAM method (Tusher et al., 2001) shrinks the raw variance estimates by
adding a constant to the estimated standard deviation. Lo¨nnstedt & Speed (2003) use
a hierarchical model with exchangeable gene variances to shrink the variance estimates.
As well as the uncertainty in expression due to biological variability, there are sys-
tematic effects in gene expression measurements due to differences between arrays. Ad-
justment for this is known as normalization. In many cases, it has been found necessary
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to go beyond simple (constant) normalization procedures and to make this adjustment
dependent on the level of expression (Schadt et al., 2000), and various algorithms have
been proposed to deal with this (e.g. Schadt et al., 2000; Kepler, Crosby, & Morgan,
2002; Workman et al., 2002) in a pre-processing step of the analysis.
In this paper, we propose an integrated statistical approach where intrinsic biological
variability, systematic array effects and differential expression are modelled simultane-
ously. Our starting point is an ANOVA formulation, as suggested by Kerr, Martin, &
Churchill (2000). This is the first level of a Bayesian hierarchical model, the distribu-
tion of the gene variances being modelled at the next level. We estimate our model in a
fully Bayesian way, with the WinBUGS software (Spiegelhalter, Thomas, & Best, 1999).
This enables us to obtain the posterior distribution of any parameter in the model and
any function of parameters. We show how to exploit these posterior distributions to
assess differential expression in a new way, using multiple criteria. The uncertainty in
parameter estimates is thereby incorporated in a natural manner into a declared list of
interesting genes. A Bayesian estimate of the false discovery rate (FDR; Benjamini &
Hochberg, 1995; Storey, 2002) is used to find a reasonable cut-off point on the list.
Several people have carried out Empirical Bayes analysis on microarray data (Efron
et al., 2001; Lo¨nnstedt & Speed, 2003; Newton et al., 2004). Other fully Bayesian
approaches include Ishwaran & Rao (2003) and Bhattacharjee et al. (2004).
Details of the data used to motivate the model in this paper are given in Section 2.
Our integrated model for differential expression is presented in Section 3. The model is
justified with exploratory work and model checks in Section 4. Section 5 discusses the
advantages of the integrated model over a two-step procedure where data is normalized
in a pre-processing step. Results obtained from implementing the full model on our
data set, with discussion of FDR, decision rules and Gene Ontology annotations, are
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given in Section 6. We conclude with a brief discussion.
2. Data
The Cd36 gene has been found to play an important role in the syndrome of insulin-
resistance (Aitman et al., 1999). Cd36-deficient mice and rats have defective metabolism
of fatty acids and triglycerides. The data used in this paper derives from a set of
experiments on three wildtype mice and three mice with Cd36 removed (Febbraio et al.,
1999). Samples of peritoneal fat were taken from each animal. RNA from the 6 samples
was hybridized on Affymetrix U74A-C chips, making a total of 18 microarrays.
The exploratory work in Section 4 was done on all 18 arrays. Results in Section 6
are shown for the U74A chip data (6 arrays). This set of data can be thought of as
3 repeat measurements of 2 conditions (wildtype and knockout) for each of the 12488
genes represented on the U74A chip. One gene with three identical measurements under
one condition is excluded from our analysis, as our model estimates variances on the
log scale, thus the dataset used in Section 6 contains 12487 genes.
The expression data we use are the output of the Affymetrix MAS 5.0 software
(Hubbell, Liu, & Rui, 2002). Since the distribution of these values is strongly skewed,
we model them on the log scale. There has been much work done on alternative data
transformations, mostly variants on the log transformation (e.g. Huber et al., 2002). We
use the log transformation for simplicity, but other transformations could be considered.
The log transformation has the advantage that the parameter δg defined in the next
section can be interpreted as the log fold difference.
3. Bayesian Hierarchical Model for Differential Expression
3.1 The Model
We start with an ANOVA model, as suggested by Kerr et al. (2000), where log gene
expression ygsr for gene g, condition s = 1, 2 and replicate r is modelled with additive
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effects for gene and array:
yg1r ∼ N(αg − 1
2
δg + βg1r, σ
2
g1)
yg2r ∼ N(αg + 1
2
δg + βg2r, σ
2
g2) (1)
where αg is the gene effect or overall expression level, βgsr is the array effect (this
normalizes the arrays) that depends on g through αg (see below), and σ
2
gs is the gene-
specific variance for condition s. The differential effect between conditions is δg.
The array effect is a function of the expression level, βgsr = fsr(αg). For flexibility,
we choose fsr to be a quadratic spline:
βgsr = b
(0)
sr0 + b
(1)
sr0(αg − a0) + b(2)sr0(αg − a0)2 +
K∑
k=1
b
(2)
srk(αg − asrk)2I[αg ≥ asrk] (2)
where the polynomial coefficients b
(p)
srk and knots asrk are unknown parameters which
are estimated as part of the model. The number of knots K is fixed (but sensitivity to
different choices of K can be investigated as part of model checking).
The equations (1) and (2) define the first level of the hierarchical model. At the sec-
ond level, information is shared between genes to stabilise the variances. The variances
are modelled as exchangeable within each condition, i.e. the variances are assumed to
come from a common distribution, chosen here to be log Normal:
σ2gs ∼ logNorm(µs, η2s). (3)
The third level of the model specifies prior distributions for all the unknown para-
meters, which are intended to be non-informative. The gene-effects αg and knots asrk
are Uniformly distributed on (a0, aK+1) where a0 and aK+1 are fixed lower and upper
limits (chosen to be wide enough not to affect the results). Polynomial coefficients b
(p)
srk
have independent N(0, 102) priors and the hyperparameters µs and η
−2
s have N(0, 10
3)
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and Gamma(10−2, 10−2) priors respectively. In this work, the differential effects δg are
given independent N(0, 104) priors.
The model in equation (1) is unidentifiable as it stands, since constants can be
transferred between the gene, array and differential effects for each gene, so constraints
must be imposed on the parameters. Our choice is to normalize in a non-linear way
within each condition by setting β¯gs. = 0 ∀ g, s, where the dot indicates that we are
taking an average over the index r. This fully identifies the model. Normalizing using
all genes within condition seems reasonable, as we do not expect systematic differences
between genes on replicate arrays.
3.2 Confounding between Array Effects and Differential Effects
In our model we normalize within each condition. Alternatively, normalization
across replicates and conditions is achieved by setting β¯g.. = 0 ∀g (average taken over
s and r). This set of constraints is a subset of the within condition constraints β¯gs. =
0 ∀ g, s; it is insufficient to identify the model fully. Normalization across replicates and
condition is usually completed by setting δg = 0 for some control genes (e.g. Kepler
et al., 2002). It is important to realise that normalizing across replicates and conditions
in a pre-processing step for all genes and not solely for the controls implicitly assumes
all δg = 0 which means the δg estimated in a subsequent model are mis-specified.
3.3 Implementation
We estimate the model in a fully Bayesian way, using the WinBUGS software
(Spiegelhalter et al., 1999) to perform Monte Carlo Markov Chain (MCMC) simulations
of the posterior distribution. The WinBUGS code is given in the supplementary mater-
ial. The constraints β¯gs. = 0 are imposed by defining quantities zgs ∼ N(β¯gs., 10−6) and
giving the program “dummy data” zgs which are equal to zero for all g and s. Since
the variance of the zgs is so small (10
−6) this construct forces the β¯gs. to be very close
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to zero (e.g. for the U74A wildtype data the maximum β¯gs. = 4× 10−4).
We allow 10,000 iterations for the sampler to converge and another 10,000 for sam-
pling the joint posterior. Convergence is checked visually and by using several starting
points. The 10,000 posterior samples are thinned to 1000 for estimating the posterior
distribution of quantities of interest. For each of the parameters αg, δg, βgsr, σ
2
gs the
Monte Carlo errors (as estimated using the batch method in WinBUGS) are around
3% of posterior standard deviation for most genes, less than 5% for 99% of the genes,
and less than 7% for all genes. In Sections 4.2, 5 and 6 we use predictive p-values and
posterior probabilities, which are estimated by means of indicator functions. For all
genes, the MC errors for these quantities are less than 5%, except for the genes with
posterior probability very close to zero, which have larger errors. For our purposes we
are not interested in genes with very low probability, however.
The WinBUGS software is particularly user friendly, but due to its general purpose
nature can be slow for treating the very large data sets common in genomics applica-
tions. For the full model processing 74,922 data points, 1000 iterations take 2 hours 50
minutes on a dual processor 2.4 GHz machine running version 1.4 of WinBUGS under
Windows. In the future, we will develop faster, purpose built code.
3.4 Rules for Selecting Genes
As we obtain the joint posterior distribution of all parameters, a rich variety of
inference criteria can be used. The main biological quantities of interest are the differ-
ential effects δg and the overall level of expression αg. In the spirit of a volcano plot,
we propose to use the joint posterior on both these parameters to pick genes:
pg ≡ P(|δg| > δcut and αg > αcut| data ) (4)
Genes are selected if pg ≥ pcut. This rule is used in Section 6 to analyse our data
set. In Section 5, on simulated data, we use a simpler decision rule based only on the
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differential effects: if we define p
′
g ≡ P(δg > δcut), we declare genes positive if p′g ≥ pcut.
These posterior probabilities are easily estimated by counting the proportion of MCMC
samples for which the chosen criteria are true.
The choice of δcut and αcut correspond to statements of biological interest. The
choice of pcut is determined by the evaluation of the False Discovery Rate (and/or False
Non-discovery Rate), see Section 6.
4. Model Checking
In this section, we present analyses carried out on biological replicate data. These
consist of 3 repeat measurements for each gene, obtained from the same strain of mouse
under the same experimental condition. The estimated model is thus as given in Section
3 but restricted to one condition (s = 1), with δg = 0. We carried out the exploratory
work in this simpler setting to focus on array effects and not on differential effects.
Results are displayed here for one particular set of 3 arrays, the wildtype data on chip
U74A, but we reached similar conclusions for the other replicate data sets in this study.
4.1 Exploratory Analysis of Array Effects
We explore the form of the array effects by splitting the data into equal sized groups
based on average expression level across the 3 arrays. In order to have a sufficient
number of genes per group, we split the genes into 6 groups. For each group j, we fit
a model with constant array effect βj1r and variances σ
2
j1, j ∈ {1, ..., 6},
yg1r ∼ N(αg + βj1r, σ2j1). (5)
The array effects are subject to the constraints β¯j1. = 0 to ensure identifiability.
The posterior mean of the array effects for the 6 groups, βj(g)1r, are shown as hor-
izontal straight lines in the left hand panel of Figure 1, plotted against the expression
levels αg. The array effects show a clear non-linear trend with expression level, not
7
compatible with random fluctuations around a constant effect. We have found similar
patterns in all sets of three replicated arrays studied. Similarly, Schadt et al. (2000)
looked at a large number of Affymetrix data sets and found many array pairs needed a
non-linear normalization effect. FIGURE 1 ABOUT HERE
The array effects shown in Figure 1 cross over each other. This means that, on the
same array, if genes with relatively low expression are normalized upwards, genes with
relatively high expression are normalized downwards, and vice versa. A constant array
effect would normalize all genes either upwards or downwards together, and so would
give qualitatively different results.
We include expression level dependent normalization in our model using equations
(1) and (2). For the U74A wildtype data set, we have fitted (2) using three different
functions for fsr(αg), a single quadratic, a quadratic spline with one knot and a single
cubic:
βgsr = b
(0)
sr0 + b
(1)
sr0(αg − a0) + b(2)sr0(αg − a0)2 + b(3)sr0(αg − a0)3. (6)
All give similar looking results and are superimposed on the cubic curves which are
shown in Figure 1 (middle panel). In order to inform our choice of f(.) in (2), we
used the deviance information criterion (DIC) proposed by Spiegelhalter et al. (2002),
designed to assess fit versus complexity of different models. For this data, the single
cubic has the lowest DIC value of the three. In all our subsequent results for this data
set, we therefore use the model with cubic array effects, though we recommend starting
with the spline form in equation (2) as a more general non-linear function.
4.2 Predictive Checks on Prior for Gene Variances
The Bayesian setting has the desirable feature of allowing us to criticise various
aspects of the model from a predictive point of view. Here we choose to investigate
the prior distribution of the gene variances as it is an important aspect of the model.
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We consider 4 possibilities: an “equal variance model” where σ2gs ≡ σ2s and σ2s ∼
logNorm(0, 104), the exchangeable log Normal variance model presented in Section 3, an
exchangeable variance model with a 1-parameter Gamma distribution on the variances:
σ−2gs ∼ Gam(2, βpriors ); βpriors ∼ Gam(10−2, 10−2) and an exchangeable model with a
2-parameter Gamma: σ−2gs ∼ Gam(αpriors , βpriors );αpriors ∼ Gam(10−2, 10−2); βpriors ∼
Gam(10−2, 10−2). A plot of the smoothed variances (using the exchangeable log Normal
prior) showing the amount of shrinkage is given in the supplementary material.
In order to assess the fit of the variance part of each model, we compare, by way
of a Bayesian “p-value”, the observed sample variance for each gene (calculated on the
3 replicates) to that evaluated using predictive values for each gene under the model.
The distribution of p-values for all 12487 genes is then used to assess the overall fit of
the variance part of the model.
For the equal variance model, we use posterior predictive p-values (Gelman, Meng,
& Stern, 1996), taking the sample variance as the discrepancy measure. For each gene,
new data for the r replicates is predicted from the model, y
(pred)
gsr ∼ N(αg+ fsr(αg), σ2s),
and the predicted sample variance S
2(pred)
gs calculated. For the exchangeable mod-
els, we use mixed predictive p-values (Gelman et al., 1996; Marshall & Spiegelhalter,
2003). These differ from posterior predictive p-values in that a new variance para-
meter σ
2(pred)
gs is first predicted for each gene, and secondly new data is predicted:
y
(pred)
gsr ∼ N(αg + fsr(αg), σ2(pred)gs ). In each case the distribution of the predicted sample
variance is compared to the observed sample variance, S
2(obs)
gs , by computing a p-value
P(S2(pred)gs > S2(obs)gs ). The supplementary material includes a directed acyclic graph for
both exchangeable and equal variance models that highlights the difference between
mixed and posterior predictive p-values.
Under the null hypothesis of the model being “true”, the distribution of the p-
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values is almost uniform (Bayarri & Berger, 2000). Since the data from a particular gene
influences its prediction, the p-values are shrunk towards 0.5, i.e. they are conservative.
Mixed predictive checks have been shown to be much less conservative than posterior
predictive checks (Marshall & Spiegelhalter, 2003). FIGURE 2 ABOUT HERE
Figure 2 shows histograms of the p-values for the 4 models for the wildtype data
(s = 1) on chip U74A. The equal variance model has a large number of small and
large p-values, indicating that this model does not allow enough variability for the
data. If these p-values were corrected for their conservativeness, they would show even
stronger evidence against the equal variance model. The exchangeable variance models
fit the data much better. Having only 1 parameter in the prior for the variances still
does not allow enough variability, but with 2 parameters both Gamma and log Normal
priors seem adequate. Furthermore, there are no extremely small p-values (which would
indicate individual outlying genes). We are therefore confident that the exchangeable
variance model we propose in Section 3 is appropriate for this data set.
5. Comparison of Integrated and Non-integrated Analyses
The problem of estimating functions of the gene effects simultaneously with the gene
effects themselves is similar to a measurement error problem, where covariates in a
regression are not measured accurately but have some unknown variability. It is well
known that in such problems ignoring this variability leads to a bias in estimates of
regression coefficients (e.g. Carroll et al., 1995). Therefore, we would expect to obtain
biased estimates of the array effects if they are estimated in a pre-processing step, which
in turn will lead to worse estimates of the differential effects δg. To illustrate this, we
compare the results from the full model with those found by pre-normalizing the data
using array effects from local regression smoothing (loess).
We simulate a microarray data set with 1000 genes and 3 repeat arrays under 2
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conditions. The gene effects αg range uniformly between 0 and 10, and the array effects
are functions of the gene effects:
βgsr = 5× 10−3 × (xgsr − x¯gs.) (7)
where xg11, xg12, xg13, xg21, xg22, xg23 are (αg − 5)3,−5(0.3αg − 4)3, 2(αg − 5.5)3,−(αg −
4)3, 5(0.05αg − 7)3 + 103, 2(αg − 5.5)3 respectively. The gene variances are simulated
from the model we fit (equation 3), with µ1 = −1.8, µ2 = −2.2, η2s = 1 for s = 1, 2,
giving a similar range of variances to those we observed in the real data. The differential
effects δg are zero for 900 genes, N(log(3), 0.1
2) for 50 genes and N(− log(3), 0.12) for
the other 50 with the differentially expressed genes uniformly spread over the range of
αg. The right hand panel of Figure 1 shows the array effects and data points for one set
of three simulated arrays. The middle panel shows the same plot for the mouse data
set used in Section 4.1, using posterior means for the array effects.
To calculate loess estimates of array effects, we use the R function “loess” with
ygsr − y¯gs. as a function of y¯g... The array effects βˆloessgsr are the values of the loess curve
for sample s and array r predicted at y¯g...
We have performed 5 simulations of the above set-up. For each of the 6 arrays we
obtain the mean square error (MSE)
∑
g(βˆ
est
gsr − βtruegsr )2 for both the loess array effects
and for those found in the full model. In 28 out of the 30 array-simulations, the loess
MSE is bigger than the full-model MSE. The ratios of loess MSE to full-model MSE for
the 6 arrays are 1.5, 1.3, 1.2, 1.2, 1.4, 1.3 (averages for the 5 simulations). As expected,
the integrated model obtains estimates of the array effects closer to the true values than
those found by loess smoothing.
The quantities of real interest are the differential effects δg. In order to assess the
effect on these of using a pre-processing step, we fit a model where we pre-normalize
the data by subtracting point estimates of the array effects: y
′
gsr ≡ ygsr − βˆgsr, and
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run our model as in Section 3 without array effects. We have done this for 2 different
cases: the first with βˆgsr = βˆ
loess
gsr and the second with βˆgsr = E(βgsr| data ) from the
full model.
The δg found by using the two pre-normalized models are very close. The differ-
ences between the loess procedure and the full model do not come from the way the
array effects are computed but from using a two step procedure as opposed to the
full integrated model. Here we show the results from the pre-normalized model using
βˆgsr = βˆ
loess
gsr since this is what is usually done in practice. FIGURE 3 ABOUT HERE
We use the simpler rule proposed in Section 3.4 to pick a list of genes: if P(δg >
δcut| data ) ≥ pcut then gene g is selected. Based on this, we can calculate the number
of false positives and negatives. Figure 3 shows the observed false discovery rate (FDR:
the number of false positives divided by the number of genes declared positive), and the
analogous false non-discovery rate (FNR), for both the full and pre-normalized models,
as a function of the cut-off probability pcut, for a choice of δcut = log(3). Graphs shown
are curves averaged over the 5 simulations. The full and pre-normalized models have
very similar FNR (only a small fraction of genes are differentially expressed), while the
FDR is consistently lower for the integrated model than for the pre-normalized model.
The difference shown here between the full and pre-normalized models is fairly small,
as the simulation is inspired by the data we use in this paper, which has small array
effects. In general, the larger the magnitude of array effects, the larger the difference
between the pre-normalized and integrated models.
6. Application to Mouse Data set
6.1 Discussion of Decision Rules
So far we have concentrated on producing a flexible model, well-grounded in the
data. Here we discuss the output of the model applied to the data set discussed in
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Section 2 and illustrate our chosen decision rule. The results shown use a subset of the
arrays from the full study (wildtype and knock-out mice on U74A chips) in order to
illustrate the generic methodology we propose.
Figure 4 shows point estimates of log fold change E(δg| data ) versus overall expres-
sion E(αg| data ). It can be seen that genes with low overall expression have a greater
range of fold change than those with higher expression. For this reason, it is appropriate
to use the rule proposed in Section 3.4 (Equation 4) where pg ≡ P(|δg| > δcut and αg >
αcut| data ) and genes are selected if pg ≥ pcut. We use αcut = 4 as this corresponds to
a background level of 54 on the original scale of the data, and δcut = ln(2) as this is a
(conservative) value often used in microarray analysis. FIGURE 4 ABOUT HERE
Genes with probability pg greater than 0.5 and 0.8 are highlighted in Figure 4. There
are 280 genes with pg ≥ 0.5, 140 over-expressed and 140 under-expressed, and 46 with
pg ≥ 0.8, 30 over-expressed and 16 under-expressed. The gene Cd36, which is expected
to be under-expressed in this data, is also marked in Figure 4. It stands out clearly
from the bulk of the genes. The value of pg for Cd36 is 0.49.
To determine an appropriate probability cut-off pcut, we can calculate an estimate
of the false discovery rate (FDR) based on the decision rule above. Here δcut and
αcut determine H0 (so must be chosen beforehand). This type of null distribution is
similar to those used in bioequivalence studies, where a cut-off is chosen to indicate a
biologically relevant difference (e.g. Bickel, 2004). It is a composite hypothesis rather
than the more usual point hypothesis. We estimate the FDR as in Newton et al.
(2004), by 1|S(pcut)|
∑
g∈S(pcut)(1− pg), where S(pcut) is the group of genes with pg ≥ pcut
and |S(pcut)| denotes its cardinality. The analogous false non-discovery rate (FNR) is
estimated in a similar way. An FDR of 10% corresponds to a probability cut-off of 0.83.
The number of genes obtained using this cut-off is 33 and the estimated FNR in this
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case is 7%. These values depend on the chosen δcut and αcut, of course, which determine
the null hypothesis under consideration.
The quantities pg are a convenient way to combine biological significance with sta-
tistical significance. Statistical significance is ensured in the usual way through use
of the posterior probability. The pg increase with the standardised log fold difference
tg ≡ E( δg√
(σ2g1+σ
2
g2)/3
| data ), which is analogous to a t-statistic (though using shrunken
variance estimates), so requiring high pg is partly similar to performing a t-test (see
Figure 5). The biological significance is determined by the cut-off on the fold differ-
ence δcut. If genes were selected using only tg, many genes with low fold difference
would be declared as statistically significant. For example, there are 118 genes above
background (E(αg| data ) > 4) with |tg| ≥ 2.78 (corresponding to a 95% confidence
interval for a t-test with 4 degrees of freedom). These genes are shown as green tri-
angles in Figure 5). Of these, a large proportion (32/118) have low fold difference
|E(δg| data )| < log(2). This can be seen in the left hand panel of Figure 5: the vertical
lines mark |E(δg| data )| = log(2). FIGURE 5 ABOUT HERE
6.2 Analysis of Gene Ontology terms
In order to illustrate the biological significance of the genes found by the above
rule (Equation 4), we compare the Gene Ontology (GO) annotations of these genes
(the “query group”) with the annotations of a reference group made up of the least
differentially expressed genes. The query group is defined by pg ≥ 0.5, giving 280
genes. The reference group is all genes with pg ≤ 0.2 (11171 genes). When these lists
are reduced to genes with both Gene Symbol and GO annotation, we retain 95 query
versus 4931 reference genes.
The Gene Ontology can be represented as a directed acyclic graph relating biolog-
ical terms of different degrees of specificity, with directed links from less specific to
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more specific terms. Each term can have several parents (broader related terms) and
children (more specific related terms). Annotation of a gene to any given term A im-
plies automatic annotation to all ancestors of A (the set of broader terms related to
A by directed paths). For each GO term we perform a Fisher’s exact test using the
FatiGO website (Al-Shahrour et al., 2004), to compare the proportions of genes in the
query and reference groups annotated to that term. Our definition of a GO term being
“significant” is a p-value less than 0.05 and (for terms over-represented in the query
group) annotations for 3 or more genes on the query list. For this interpretative step
we do not use multiple testing corrections as there is a large amount of dependency
between tests, due both to genes being annotated in several categories and to the graph
structure of the Gene Ontology. Since we use a conservative criterion in our definition
of pg this seems reasonable. TABLE 1 ABOUT HERE
The left-hand column of Table 1 shows the most specific GO terms that are found
significant according to this criterion. The right-hand column shows the ancestors
(broader terms) in the ontology of these terms that are found significant. Also shown
are the observed and expected numbers of genes in the query group annotated to each
term. Expected numbers are calculated by multiplying the percentage of annotations
in the reference group with the number of genes in the query group.
It can be seen that many of the ancestors of “inflammatory response” are signifi-
cant (in fact only one ancestor of this term is not significant). This result is of interest
in view of the emerging observations of the importance of inflammation-related genes
in adipocyte biology (Cle´ment et al., 2004). A graph showing the relations between
“inflammatory response” and all its ancestors is included in the supplementary ma-
terial. In addition, the significant over-representation of lipid catabolism and under-
representation of protein transport are consistent with the known biological functions
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of Cd36 in metabolism (Aitman et al., 1999).
7. Discussion
We have presented a unified Bayesian hierarchical model for differential gene expression
incorporating both non-linear array effects and exchangeable gene variances, and have
justified our functional choices by exploratory analysis. We have drawn attention to the
issue of confounding between array and differential effects, and shown how analysing
the data in a two step process can lead to a greater number of false positives. Bayesian
joint estimation of differential effects and array effects has also been carried out in a
recent paper by Bhattacharjee et al. (2004).
The Bayesian formulation enables us to obtain a much richer output from our model
than most current analyses. Our method for choosing lists of genes provides a straight-
forward way to rank genes using multiple criteria, and a suitable cut-off on the list can
be chosen based on the estimated false discovery rate.
Expert opinion is used to set suitable cut-offs on the log fold change and (optionally)
overall expression level. The “null hypothesis” formulated here is composite. If a point
null hypothesis is required, a mixture model can be used to classify genes and estimate
the FDR (Lo¨nnstedt & Speed, 2003; Newton et al., 2004), and we intend to explore
this in further work. Another interesting fully Bayesian model has been developed by
Ishwaran & Rao (2003). Their approach is complementary to ours: we use a flat prior
on the differential effects but shrink the gene variances while they shrink the differential
effects, using a “spike and slab” variable selection approach, but use raw variances that
in their main model are not gene-specific. Gene lists are then formed using t-statistics.
One interesting alternative would be to look at distributions of gene ranks, for
instance based on fold change. Simply ranking genes based on point estimates of fold
change is not enough, as some highly ranked genes will have high variability and some
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will have low variability. By looking at the distributions of ranks (easily obtained in the
Bayesian approach) one can find the highly ranked genes with the lowest variability.
The probability statements made so far have been on a gene by gene basis, but in
this framework, we can also make joint statements about the genes that circumvent in
some way the problem of multiple testing. For example, for a given list of genes derived
from independent biological information, we can make joint statements such as: “the
probability (conditional on the data) that 80% of genes {g1, . . . , gn} have δg > log(2)
is at least 0.80”, which can be readily interpreted by biologists. Statements about the
joint distribution of the ranks could also be made.
We have implemented our model using the WinBUGS software for ease and ubiquity
of use and the code is available (see supplementary material). For a much larger number
of arrays, it will become unfeasible to use WinBUGS and we are in the process of
developing code that would cut the computing time by a substantial fraction.
The ideas in this paper apply to data from cDNA chips as well as Affymetrix, with
extra terms included to account for within slide normalization. In future work, we aim
to include in the hierarchical specification another layer consisting of the Bayesian signal
extraction model for Affymetrix PM’s and MM’s as proposed in Hein et al. (2005).
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Figure 1. Left panel: Array effects as functions of gene expression level for the wildtype
mouse fat hybridized to chip U74A. The straight lines are the posterior means of the
array effects found by fitting model 5 on the relevant expression level range for the data
divided into 6 groups. Dashed, dotted and dot-dash lines represent one array each. The
smooth curves (dashed, dotted and dot-dash) are the posterior means of the cubic array
effects from our model (equations 1, 3 and 6). Middle panel: Array effects as functions
of gene expression level for the wildtype mouse fat hybridized to chip U74A. Lines are
the posterior means of the cubic array effects from our model. Points are the data points
with the overall gene expression level subtracted for each gene (ygsr − E(αg| data )).
Right panel: Array effects βgsr (lines) used for three of the simulated arrays in section
5 of the main paper. The points on the plot are the simulated data points with the
overall gene expression level subtracted for each gene (ygsr − αg). Note the similarity
of spread and array effects between simulated and mouse data.
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Figure 2. Mixed and posterior predictive p-values for the wildtype mouse U74A data
(s=1) obtained from fitting the model with equal variances, exchangeable variances
with a 1-parameter Gamma prior, exchangeable variances with a 2-parameter Gamma
prior and exchangeable variances with a 2-parameter log Normal prior (as discussed in
Section 3).
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Figure 3. Observed false discovery rate (FDR) and false non-discovery rate (FNR)
versus probability cut-off pcut for the simulated data set described in Section 5. The
solid line is for the full, integrated model and the dashed line is for the pre-normalized
model. All curves are averages over 5 simulations.
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Figure 4. Posterior means of log fold change E(δg| data ) and gene expression level
E(αg| data ) for the U74A chip. Genes with pg ≥ 0.5 are plotted with triangles and
those with pg ≥ 0.8 with crosses. The arrow indicates the gene Cd36, whose pg is 0.49.
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Figure 5. Posterior probabilities pg versus log fold difference (left hand panel) and
versus standardised log fold difference (right hand panel) for genes above background
(E(αg| data ) > 4). Genes with pg ≥ 0.83 (corresponding to an estimated FDR of 10%)
are shown as blue crosses, while genes with |tg| ≥ 2.78 (but not pg ≥ 0.83) are shown
as green triangles. All except two of the genes with pg ≥ 0.83 have |tg| ≥ 2.78. The
vertical lines show where |E(δg| data )| = log(2).
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Most specific “significant” terms Ancestor terms also “significant” (GO level > 3)
inflammatory response (O=4, E=1.2) immune response (O=9, E=4.5)
response to pest, pathogen or parasite (O=8, E=2.6)
response to wounding (O=6, E=1.8)
defense response (O=11, E=5.8)
response to external stimulus (O=12, E=4.7)
response to biotic stimulus (O=14, E=6.9)
response to stress (O=12, E=5.9)
neuromuscular physiological process neurophysiological process (O=8, E=2.6)
(O=5, E=1.3) organismal movement (O=7, E=1.9)
transmission of nerve impulse (O=5, E=1.3) neurophysiological process (O=8, E=2.6)
cell-cell signaling (O=5, E=1.9)
DNA repair (O=4, E=1.3) response to stress (O=13, E=5.9)
nucleobase, nucleoside, nucleotide and
nucleic acid metabolism (O=15, E=23.8)
lipid catabolism (O=3, E=0.6) -
protein transport (O=0, E=5.0) -
fertilization (O=3, E=0.2) -
Table 1
The left column shows the most specific GO terms found significant. The right-hand
column shows the ancestors (broader terms) in the ontology of these terms that are
also found significant. Numbers in brackets indicate observed (O) and expected (E)
numbers of genes in the query list (those most differentially expressed) annotated to
the term. Expected numbers are calculated by multiplying the percentage of
annotations in the reference group with the number of genes in the query group.
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